NL-OMON29359招募中不适用
Randomized, double-blind, placebo-controlled single ascending dose study to assess the safety and tolerability of AP30663 in healthy subjects
Acesion Pharma ApSOle Maaløes Vej 3DK-2200 Copenhagen NDenmark0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 48
研究概览
简要总结
To be published
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Signed informed consent prior to any study-mandated procedure
- •2. Healthy male subjects, 18 to 45 years of age, inclusive.
排除标准
- •1. Evidence of any active or chronic disease or condition that could interfere with, or for which
- •the treatment might interfere with, the conduct of the study, or that would pose an
- •unacceptable risk to the subject in the opinion of the investigator (following a detailed
- •medical history, physical examination, vital signs (systolic and diastolic blood pressure, pulse
- •rate, body temperature), 12-lead electrocardiogram (ECG), and clinical laboratory
- •parameters (haematology, blood chemistry, and urinalysis)). Minor deviations of laboratory
- •values from the normal range may be accepted, if judged by the Investigator or medically
- •qualified designee as not clinically significant.
研究者
相似试验
撤回
3 期
Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry DiseaseFabry DiseaseNCT02921620Protalix
终止
1 期
Safety Study of SLV213 for the Treatment of COVID-19.COVID-19NCT06146374National Institute of Allergy and Infectious Diseases (NIAID)16
已完成
3 期
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) PatientsPhenylketonuriaNCT01114737BioMarin Pharmaceutical206
已完成
不适用
•Research study to investigate the safety, tolerability and effects of multiple doses of LTI-291 in patients with Parkinson’s Disease with a GBA1 mutation.PD patients with a GBA1 mutation , movement disorderNL-OMON23923•Lysosomal Therapeutics, Incorporated40
进行中（未招募）
不适用
Study to assess the clinical efficacy and safety of SUBLIVAC FIX Birch immunotherapy in patients with allergic rhinitis/rhinoconjunctivitis caused by birch polleModerate to severe birch pollen induced allergic rhinitis/rhinoconjunctivitis with or without mild to moderate persistent asthma.MedDRA version: 17.1Level: LLTClassification code 10001726Term: Allergic rhinitis due to pollenSystem Organ Class: 100000004870EUCTR2013-005550-30-BEHAL Allergy B.V.400